Dolby Laboratories Inc (DLB) Stock AnalysisDLBDolby Laboratories Inc

Dolby Laboratories, Inc. is engaged in designing and manufacturing of audio and imaging hardware and software products for the cinema, television, broadcast and entertainment industries. The two primary components of its licensing business are Branded Technologies, which include Branded Audio Codecs, Dolby Atmos & Dolby Vision, and Patents, which include Audio Patents and Imaging Patents. The Company's cinema imaging products include digital cinema servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode and package digital media files for distribution. Its cinema audio products include cinema processors, amplifiers and loudspeakers used to decode, render, and optimally play back digital cinema soundtracks, including those using Dolby Atmos. It also offers various services to support theatrical and television production for cinema, broadcast, and home entertainment. It operates in the Technology sector (PATENT OWNERS & LESSORS industry).

Currently, Dolby Laboratories Inc (DLB) is priced at $58.74, with a forward P/E of 12.61 indicating it may be undervalued relative to future earnings. However, the stock has experienced a 14.55% decline over the past year and insider selling has surged by 1552.33% recently, which is a significant red flag. The RSI is at 51.068, suggesting the stock is neither overbought nor oversold, indicating a wait-and-see approach may be prudent.

7 analysts cover DLB: 5 rate it Buy, 2 Hold and 0 Sell. The average price target is 87.50.